DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas

Information source: Midwest Pulmonary and Critical Care
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pleural Effusion Associated With Pulmonary Infection; Bacterial Pleural Effusion Other Than Tuberculosis

Intervention: Alteplase (Drug); Placebo (Drug)

Phase: N/A

Status: Completed

Sponsored by: Midwest Pulmonary and Critical Care

Official(s) and/or principal investigator(s):
George Thommi, MD, Principal Investigator, Affiliation: Midwest Pulmonary and Critical Care, PC

Summary

The purpose of this study is to document the efficacy and safety of intrapleural instillation of Activase vs Placebo in the management of complicated pleural effusions and empyemas

Clinical Details

Official title: Response to Instillation of Activase in the Pleural Cavity vs Placebo in the Management of Complicated Pleural Effusion/Empyema

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: No Surgical Intervention

Secondary outcome:

Number of Participants With Pneumonia That Responded to Therapy

Number of Participants With Pleural Effusion/Empyema That Responded to Therapy

Number of Participants With Shortness of Breath That Responded to Therapy

Number of Participants With Clinical Symptoms of Sepsis That Responded to Therapy

Detailed description: The current treatments available for complicated pleural effusions (CPE) include chest tube placement for drainage and IV antibiotics. If this fails and CPE occurs then in most patients thoracotomy is performed. Patients that are not surgical candidates have image guided catheter placement performed, sometimes multiple times. The American College of Chest Physicians (ACCP) formed a CPE panel and published guidelines for treating CPE. Percutaneous image-guided drainage is the most common approach for CPE. The panel recognizes the cumulative data that supports the use of fibrinolytics, VATS, and thoracotomy. The CPE panel acknowledged the lack of randomized clinical trials to determine efficacy and safety of these modalities in CPE and strongly encourages the research to take place. Fibrinolytic therapy is a relatively noninvasive, easy to use, and is relatively inexpensive. If successful, it will prevent sepsis and septic shock, decrease hospital stay, morbidity and mortality and prevent any surgical procedures. Multiple doses of fibrinolytics have been used in CPE with no evidence of systemic anti-fibrinolytic activity. Complications with these medications are also very uncommon and only isolated instances are reported. The benefit from successful pleural drainage using these agents will decrease morbidity, mortality, surgical procedures, and hospital stay.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Diagnosed with complicated pleural effusions

- Ability to provide written informed consent and comply with study assessments for the

full duration of the study.

- Age > 18 years

Exclusion Criteria

- Current use of oral anticoagulants (e. g., warfarin sodium) with an International

Normalized Ratio (INR) >5- Activated partial thromboplastin time (aPPT) > 80, Platelet count < 100,000/mm3;

- Severe uncontrolled hypertension

- Recognized hypersensitivity to Activase; or any component of its formulation;

Traumatic pleural effusion

- Pregnancy (positive pregnancy test)

- In another study for this condition

- Any other condition that the investigator believes would pose a significant hazard to

the subject if the investigational therapy were initiated

- Participation in another simultaneous medical investigation

- Recent stroke

- Intracranial hemorrhage

- arteriovenous malformation or aneurysm

- Intracranial neoplasm

- Acute myocardial infarction

- Acute pulmonary embolus

Locations and Contacts

Nebraska Methodist Hospital, Omaha, Nebraska 68114, United States
Additional Information

Starting date: April 2004
Last updated: April 25, 2012

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015